Enhanced expression of lncRNA ECRAR could substantially stimulate myocardial regeneration and induce recovery of cardiac function after MI, suggesting that ECRAR may be an effective therapeutic target for heart failure [10]. The gene discussed is PTTG1; the disease is heart failure.